Searched for
ARAGEN IPO
Aragen Life Sciences files draft papers with Sebi to raise funds through IPOAragen Life Sciences has filed its DRHP with Sebi for an IPO comprising a Rs 800 crore fresh issue and an OFS. Proceeds will fund debt repa...- Avendus set for final close of Future Leaders Fund-III at Rs 1,800 croreThe fund’s latest investment is a Rs 140 crore secondary purchase of promoter shares in Parag Parikh Financial Advisory Services (PPFAS).
- Quadria Capital weighs Encube sale, keeps public float option alive, tooQuadria Capital is exploring options to sell its stake in Encube Ethicals. The healthcare investor considers both a controlling stake sale ...
- Quadria Capital invests $100 million in Aragen LifeIn this pre-IPO round, Quadria will acquire the minority stake in Aragen, at an approximate valuation of $1.4 bn, primarily through a fresh...
- Quadria Capital to pick up minority stake in drug company AragenQuadria Capital is set to acquire a 10% stake in Aragen Life Sciences for about $100 million, valuing the Indian CRDMO at $1.2 billion. The...
- Western Carriers IPO subscribed nearly 14 times as on day 4, GMP down to 29%. Check detailsWestern Carriers' IPO has been subscribed 13.88 times, driven by strong demand from retail and non-institutional investors. The company pla...
- Arkade Developers IPO subscribed by nearly 30 times as on Day 3. Check GMP, other detailsArkade Developers' IPO has been oversubscribed 30.2 times. Analysts recommend subscribing due to the company's strategic positioning in Mum...
- Bajaj Housing Finance shares under pressure after multibagger rally. Should you buy or sell?Bajaj Finance shares rallied post-IPO but faced pressure today, declining 2%. Analysts recommend waiting for a price correction before buyi...
- Goldman-backed Aragen eyes Rs 12,000 crore as pre-IPO dose; Novo Nordisk keenInvestors including Quadria Capital and Denmark-based pharmaceutical major Novo Nordisk are among those interested in a minority stake and ...
- ChrysCapital eyes stake in Delhi's Centre For Sight eye hospitalChrysCapital's proposed investment will give an exit to Mahindra Partners, the PE arm of Mahindra & Mahindra, which owns about 32% stake in...
Load More
